March 2014

The Board of trustees of IDIBELL has approved on Tuesday March 18th in a extraordinary meeting on appointment of Dr. Jaume Reventós as IDIBELL’s director. Jaume Reventós (Barcelona, 1953) is a doctor (1977, UAB). He attended and received his specialty of Biochemistry (1982) in the MIR at the Vall d’Hebron Hospital in Barcelona. So far,

On Friday March 14th the election for electing the new IDIBELL predoctoral committee took place. After counting up, these are the new predoctoral representatives for the next two years: The turnout was 51.75% of a total census of 114 voters. The 59 votes cast were in favor of the list, 0 blank votes and 0

On Wednesday 5 March, the small hall of the University Hospital of Bellvitge (HUB) hosted a briefing on Sklodowska Marie Curie Actions of Horizon 2020 program of the European Union organized by the TTO IDIBELL. Aida Diaz, part of the team of European and International Service Projects AGAUR (SPEI-AGAUR) explained the different financing schemes for

The first Transbio Sudoe collaboration project has just been approved. It will be led byJulián Cerón, of the Bellvitge Biomedical Research Institute (Idibell), and Denis Dupuy, of the European Institute of Chemistry and Biology (IECB). The project is entitled Functional genomic analysis of the SM-like protein family in C. elegans and over the coming four

The researcher Manel Esteller, Director of Epigenetics and Cancer Biology program at the Institute of Biomedical Research of Bellvitge (IDIBELL ), ICREA researcher and professor of Genetics at the University of Barcelona has won the Vanguardia Award for Science 2013. The selected research work has been published in 2013 in the journal Genome Research and